Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 02 tags : Disease save search
Prometheus Biosciences Announces Initiation of APOLLO-CD Phase 2a Clinical Trial of PRA023 in Moderate-to-Severe Crohn’s Disease
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 0.62%
H: 1.9%
C: 1.66%
disease phase 2 trial phase 2b
Hoth Therapeutics Initiates Preclinical Study of HT-ALZ for Alzheimer's Disease
Published: 2021-08-02 (Crawled : 12:15) - ir.hoththerapeutics.com
HOTH | $1.17 -1.68% 1.2% 17K
|
Health Technology
|
| O: 4.65%
H: 1.41%
C: 0.74%
disease alzheimer preclinical alzheimer’s alzheimer's disease pre-clinical alzheimer's ht-alz
Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
FOLD 4 | $10.54 -1.59% -1.81% 1.8M
|
Health Technology
|
| O: 0.16%
H: 1.72%
C: 1.29%
disease europe approval
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
RILY | $29.75 36.97% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.